Caitlin E. Milligan
No Rating Available
(Learn About Our Rating System)

Caitlin E. Milligan, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

Pediatric Cardiology
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Primary Children's Hospital - Lehi

Pediatric Cardiology
2250 N Miller Campus Dr
Lehi , UT 84043
801-213-3599
Get Directions

  • Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Cardiology)
    National Board of Medical Examiners

  • Board Certification and Academic Information

    Academic Departments Pediatrics -Assistant Professor (Clinical)
    Academic Divisions Cardiology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Cardiology)
    National Board of Medical Examiners

    Education history

    Fellowship Advanced Cardiac Therapies - Boston Children’s Hospital Senior Fellow
    Fellowship Pediatric Cardiology - Boston Children’s Hospital Chief Fellow
    Fellowship Pediatric Cardiology - Boston Children’s Hospital Clinical Fellow
    Residency Boston Combined Residency Program in Pediatrics - Boston Children’s Hospital, Boston Medical Center Resident
    Professional Medical Medical Scientist Training Program - University of Washington School of Medicine M.D., Ph.D.
    Undergraduate Biology; Global Health Certificate - Duke University B.S.

    Selected Publications

    Journal Article

    1. Milligan C, Wong A, Bastardi H, Singh TP, Daly KP, Esteso P (2025). Daratumumab for Anti-HLA Antibody Desensitization and Antibody Mediated Rejection in Pediatric Heart Transplant Patients. Pediatr Transplant, 29(5), e70106. (Read full publication)
    2. Esteso P, Gauvreau K, Milligan C, Vo L, Fynn-Thompson F, Blume ED, Singh TP (2025). Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients. JAMA Netw Open, 8(4), e257766. (Read full publication)
    3. Kobayashi RL, Williams RJ, Gauvreau K, Daly KP, Esteso P, Milligan C, Ventreso C, Fynn-Thompson F, Chiu P, VanderPluym CJ (2024). Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology. Pediatr Cardiol. (Read full publication)
    4. Milligan C, Williams RJ, Singh TP, Bastardi HJ, Esteso P, Almond CS, Gauvreau K, Daly KP (2024). Impact of a positive crossmatch on pediatric heart transplant outcomes. J Heart Lung Transplant, 43(6), 963-972. (Read full publication)
    5. Yamasaki T, Sanders SP, Hylind RJ, Milligan C, Fynn-Thompson F, Mayer JE Jr, Blume ED, Daly KP, Carreon CK (2024). Pathology of explanted pediatric hearts: An 11-year study. Population characteristics and implications for outcomes. Pediatr Transplant, 28(4), e14742. (Read full publication)
    6. Milligan C, Mills KI, Ge S, Michalowski A, Braudis N, Mansfield L, Nathan M, Sleeper LA, Teele SA (2022). Cardiovascular intensive care unit variables inform need for feeding tube utilization in infants with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg, 165(3), 1248-1256. (Read full publication)
    7. Milligan C, Omenda MM, Chohan V, Odem-Davis K, Richardson BA, Nduati R, Overbaugh J (2016). Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk. mBio, 7(1), e02221-15. (Read full publication)
    8. Milligan C, Richardson BA, John-Stewart G, Nduati R, Overbaugh J (2015). FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission. Open Forum Infect Dis, 2(4), ofv149. (Read full publication)
    9. Milligan C, Richardson BA, John-Stewart G, Nduati R, Overbaugh J (2014). Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality. Cell Host Microbe, 17(4), 500-6. (Read full publication)
    10. Milligan C, Cuneo CN, Rutstein SE, Hicks C (2014). "Know Your Status": results from a novel, student-run HIV testing initiative on college campuses. AIDS Educ Prev, 26(4), 317-27. (Read full publication)
    11. Omenda MM, Milligan C, Odem-Davis K, Nduati R, Richardson BA, Lynch J, John-Stewart G, Overbaugh J (2013). Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection. J Acquir Immune Defic Syndr, 64(2), 163-6. (Read full publication)
    12. Goo L, Milligan C, Simonich CA, Nduati R, Overbaugh J (2012). Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope. J Virol, 86(18), 9566-82. (Read full publication)
    13. Nalluri BN, Milligan C, Chen J, Crooks PA, Stinchcomb AL (2005). In vitro release studies on matrix type transdermal drug delivery systems of naltrexone and its acetyl prodrug. Drug Dev Ind Pharm, 31(9), 871-7. (Read full publication)

    Review

    1. Milligan C, Slyker JA, Overbaugh J (2017). The Role of Immune Responses in HIV Mother-to-Child Transmission. [Review]. Adv Virus Res, 100, 19-40. (Read full publication)
    2. Milligan C, Overbaugh J (2014). The role of cell-associated virus in mother-to-child HIV transmission. [Review]. J Infect Dis, 210 Suppl 3(Suppl 3), S631-40. (Read full publication)

    Editorial

    1. Milligan C, Daly KP (2023). ABO-Incompatible Heart Transplantation: Where Science, Society, and Policy Collide. J Card Fail. (Read full publication)